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Background. Blood culture is the standard diagnostic method for typhoid and paratyphoid (enteric) fever in surveillance stud-
ies and clinical trials, but sensitivity is widely acknowledged to be suboptimal. We conducted a systematic review and meta-analysis 
to examine sources of heterogeneity across studies and quantified the effect of blood volume.
Methods. We searched the literature to identify all studies that performed blood culture alongside bone marrow culture (a gold stan-
dard) to detect cases of enteric fever. We performed a meta-regression analysis to quantify the relationship between blood sample volume 
and diagnostic sensitivity. Furthermore, we evaluated the impact of patient age, antimicrobial use, and symptom duration on sensitivity.
Results. We estimated blood culture diagnostic sensitivity was 0.59 (95% confidence interval [CI], 0.54–0.64) with significant 
between-study heterogeneity (I2, 76% [95% CI, 68%–82%]; P < .01). Sensitivity ranged from 0.51 (95% CI, 0.44–0.57) for a 2-mL 
blood specimen to 0.65 (95% CI, 0.58–0.70) for a 10-mL blood specimen, indicative of a relationship between specimen volume and 
sensitivity. Subgroup analysis showed significant heterogeneity by patient age and a weak trend towards higher sensitivity among 
more recent studies. Sensitivity was 34% lower (95% CI, 4%–54%) among patients with prior antimicrobial use and 31% lower after 
the first week of symptoms (95% CI, 19%–41%). There was no evidence of confounding by patient age, antimicrobial use, symptom 
duration, or study date on the relationship between specimen volume and sensitivity.
Conclusions. The relationship between the blood sample volume and culture sensitivity should be accounted for in incidence 
and next-generation diagnostic studies.
Keywords. blood culture; bone marrow culture; diagnostic accuracy; paratyphoid fever; typhoid fever.
 
Salmonella enterica serovar Typhi is the causative agent of 
typhoid fever, for which there are an estimated 17.8 million cases 
per year; S enterica serovars Paratyphi A, B, and C cause a clin-
ically indistinguishable syndrome and contribute an additional 
4.6 million cases per year [1, 2]. Most of this burden occurs in 
low- and middle-income countries (LMICs), where the clini-
cal presentation of typhoid fever overlaps with the symptoms of 
many other diseases, such as malaria and dengue [3].
For a definitive diagnosis of typhoid or paratyphoid (enteric) 
fever, the World Health Organization recommends bacterial 
isolation from blood or bone marrow [4]. Bone marrow culture 
(the gold standard) is acquired via aspirate of the iliac crest or 
sternum and has a suggested sensitivity of ~90% after 4 days of 
culture [5, 6]. However, due to the invasive nature of bone mar-
row biopsies, the diagnosis of enteric fever in LMICs typically 
depends on blood culture or the Widal test, an antibody titer 
test with markedly poor specificity (~77%) [4, 7, 8]. Blood cul-
ture has been the de facto diagnostic test for population-based 
incidence studies, vaccine trials, as well as the reference stan-
dard for novel diagnostics [6, 9, 10].
Blood culture diagnostic sensitivity is characterized by 
heterogeneity, with estimates ranging between 40% and 
87% [6]. Some of this variation could be explained by blood 
sample volume—a relationship that is commonly acknowl-
edged but has never been quantified [6, 11–14]. Specimen 
volume varies markedly between studies depending on local 
regulations and/or the patient’s age [9, 15–17]. Moreover, 
factors such as patient age (independent of specimen vol-
ume), symptom duration, previous antimicrobial use, and 
laboratory culture conditions (broth and agar used, auto-
mated culture systems) are hypothesized to influence blood 
culture sensitivity [6, 13, 18–22].
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We conducted a systematic review and meta-analysis to 
explore how patient attributes and specimen volume contrib-
ute to heterogeneity in estimates of blood culture sensitivity. We 
investigated how the relationship between blood volume and 
culture sensitivity could be impacted by the age of the patient, 
the duration of disease before specimen collection, and prior 
antimicrobial use.
MATERIALS AND METHODS
We conducted our systematic review according to an a prio-
ri-specified protocol (see, Supplement S1 & S2) and adhered 
to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines for reporting [23]. One 
author (M.A.) performed the search and screening. The data 
extraction and risk of bias assessment were conducted in dupli-
cate (M.A. and N.J.S.), and discrepancies were resolved through 
consensus or by a third reviewer (V.E.P.).
Inclusion Criteria and Search Strategy
We searched Web of Science, MEDLINE, Embase, Global 
Health, and PubMed Central for studies published before June 
19, 2016, without additional date or language restriction. We 
identified relevant publications using controlled vocabulary 
and free text related to enteric fever and blood or bone mar-
row culture (see Supplement S1). We defined eligible publica-
tions as epidemiological studies of any design that assessed the 
sensitivity of blood culture to detect typhoid or paratyphoid 
among patients who also had at least 1 sample of blood and 
bone marrow cultured for either infection. We did not include 
editorials, commentaries, or reviews (see Supplement S2). We 
screened the title and abstract of the studies identified, con-
firmed eligibility by full-text review, and identified additional 
articles by cross-checking the references of original articles 
and reviews.
Data Extraction
We extracted data on the number of positive and negative 
blood and bone marrow cultures, as well as the volume of each 
sample, if reported (see Supplement S3). We also obtained data 
on the number of additional patients identified by positive 
cultures of other sites (rose spots, rectal swab, stool, urine). 
Because some studies did not report the concordance between 
blood and bone marrow culture results, we calculated the pro-
portion of blood cultures that grew colonies of S Typhi or S 
Paratyphi (A, B, or C) among individuals with at least 1 posi-
tive culture from any site, thereby leveraging as many studies 
as possible.
Risk of Bias Assessment
We modified the QUADAS-II tool [24] to fit our research ques-
tion and assessed the risk of bias in patient recruitment, index 
test (blood culture), reference test (bone marrow culture), or the 
flow and timing of the 2 cultures (see Supplement S3).
Statistical Analysis
We used an inverse-variance weighted binomial-normal model 
to estimate the overall diagnostic sensitivity of blood cultures 
of S Typhi or S Paratyphi and used a random effects model to 
account for unmeasured heterogeneity between studies, which 
was quantified using the I2 statistic [25].
To investigate factors that contribute to heterogeneity of 
blood culture sensitivity estimates across studies, we performed 
a meta-regression analysis to assess the relationship between 
blood specimen volume and sensitivity. We specified the rela-
tionship between blood culture sensitivity and specimen volume 
in 3 ways. First, we tested a “null” model in which diagnostic 
sensitivity is independent of specimen volume. A  second and 
third model assumed that sensitivity had a log-linear relation-
ship with volume using a slope-only and a slope-and-intercept 
functional form, respectively (see Supplement S4, section 4.1). 
We compared the models based on Widely Applicable 
Information Criterion (WAIC) [26]. We also modeled sensitivity 
using a linear meta-regression model to assess the impact of the 
functional form on the relationship between specimen volume 
and sensitivity (see Supplement S4, section 4.1). We verified our 
results were robust to the definition of “true positives” (positive 
culture from any site) by re-estimating blood culture sensitivity 
and its relationship with specimen volume among patients who 
were specifically bone marrow culture-positive; studies that did 
not report the number of patients who were blood culture-posi-
tive strictly among those who were also positive by bone marrow 
culture were excluded from this analysis (n = 3).
Next, we performed a subgroup analysis to test whether het-
erogeneity across studies was attributable to the differences in 
the age of patients in the study. To evaluate whether age had a 
confounding or modifying effect on the relationship between 
specimen volume and blood culture sensitivity, we included age 
as an independent predictor and interaction term in the pri-
mary meta-regression model (see Supplement S4, section 4.2).
We also performed a  subgroup analysis on the sensitivity 
reported in studies according to the date of publication (before 
1980, 1980–1990, and after 1990, which partitions the studies 
into 3 approximately equal groups). Moreover, we performed 
meta-analyses on the diagnostic risk ratio of the duration of symp-
toms and prior antibiotic use, and we tested for a modifying effect 
of specimen volume on these risk ratios (see Supplement S4, sec-
tion 4.3). 
Analyses were performed in R version 3.3.2 and JAGS version 
3.4.0 (details are found in Supplement S4, section 4.4).
RESULTS
Inclusion and Characteristics of Studies
After screening the titles and abstracts of 2310 unique arti-
cles identified in our search, 86 articles were identified for 
full-text screening, yielding a preliminary set of 33 studies 
for data extraction. After cross-checking the reference lists of 
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the preliminary set and of systematic reviews, we identified 
an additional 21 articles for full-text review, of which 7 addi-
tional studies were eligible (Figure 1). In total, 40 studies were 
included in the systematic review and meta-analysis, yielding a 
total of 2051 patients; 25 studies reported blood specimen vol-
ume, yielding 1370 patients for the meta-regression analysis. 
Reasons for exclusion are reported in Figure 1.
Characteristics of the Studies Included
Table 1 presents the characteristics of the included studies; additional 
details are provided in Supplementary Table  S1. All but 4 studies 
(10%) were conducted in LMICs, and 38 studies (95%) were con-
ducted in urban areas. In most studies, eligibility criteria consisted 
of “clinical suspicion” of enteric fever (which was rarely described), 
but in 2 studies (Supplemental Material, Bassily 1980 and Bhutta 
1991), the patient populations were individuals suspected of chronic 
carriage of typhoid or individuals who had prolonged symptoms, 
respectively. Blood cultures were performed using a variety of tech-
niques (Supplementary Table 1); selective media were generally used, 
and a few more recent studies have used techniques to improve blood 
culture sensitivity, such as cell lysis and centrifugation; only 1 study 
reported using a Bactec (automated) system (see Supplementary 
Table  S1, Escamilla 1982). Three studies (7.5%) were conducted 
among patients of all ages, 21 studies (52.5%) were performed in a 
subset of age groups, and 16 studies (40%) did not specify patient 
age. Seven studies (17.5%) reported sensitivity stratified by antimi-
crobial use, and 15 studies (37.5%) reported sensitivity according to 
the time from symptom onset to sample collection.
Embase N = 1466
Medline (indexed) N = 177
Medline (not indexed) N = 97
Pubmed Central N = 298
Global Health N = 687
Web of Science N = 777
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram for systematic review. A systematic search in 6 databases yielded 
3502 articles, or 2310 unique articles, 86 of which were eligible for full-text review. A total of 40 studies were included in the descriptive synthesis, and 25 studies had blood 
volume information and were included in our meta-regression analysis of the relationship between blood sample volume and blood culture sensitivity.
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Meta-Analysis
The overall estimate of blood culture sensitivity was 0.59 (95% 
CI, 0.54–0.64). Figure 2 shows blood culture sensitivity for each 
study and subgroup estimates of sensitivity according to the age 
group of patients. Sensitivity was not markedly different among 
the subset of studies included in our meta-regression analysis 
(0.56; 95% CI, 0.51–0.61) or among the 34 studies that reported 
sensitivity among bone-marrow culture-positive patients only 
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Figure 2. Sensitivity of blood culture to detect typhoid fever. The sensitivity of blood culture is expressed as the proportion of patients who tested positive by blood culture 
among patients who had at least 1 positive culture (bone marrow, blood, rose spots, stools, or urine) for Salmonella Typhi or Salmonella Paratyphi. The size of the markers is 
proportional to the number of patients in the study. We reported the midpoint volume of the blood sample for studies that reported specimen volume as a range. We tested 
for heterogeneity and age-related subgroup differences via the Q-statistic, which is assumed to have a χ2 distribution with degrees of freedom equal to the number of studies 
minus 1 with noncentrality parameter equal to 0. Hoffman (1986) and Gasem (1995) (Supplemental Material) reported sensitivity on the same patient population using speci-
mens of 2 different volumes per patient, so we have taken only the results from the larger specimen in each study for the subgroup analysis by age to avoid double-counting. 
Abbreviations: BC+, blood culture-positive; BC−, blood culture-negative; CI, confidence interval. 
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(0.60; 95% CI, 0.53–0.65) (Supplementary Figure S1). However, 
between-study heterogeneity was statistically significant 
(P  <  .01) for all of these estimates (Figure  2, Supplementary 
Figure S1).
Specimen Volume
We found support for a positive relationship between sam-
ple volume and blood culture sensitivity. The observed and 
model-predicted relationship between sensitivity and sample 
volume is plotted in Figure 3; model parameters and goodness-
of-fit statistics are displayed in Supplementary Table S2. In the 
preferred model (the model with the lowest WAIC), blood cul-
ture sensitivity shows a marginal gain in sensitivity for each 
additional milliliter of blood and a “baseline” sensitivity for very 
small samples. The second-best model was one in which sensi-
tivity did not depend on sample volume, whereas the worst fit 
was obtained for a model that parameterized the relationship 
between volume and sensitivity using only a log-linear slope 
term and a fixed (zero) intercept. The results were similar when 
we modeled blood culture sensitivity among bone-marrow cul-
ture-positive patients only, although the baseline sensitivity was 
higher and the relationship with blood sample volume was atten-
uated in this analysis (Supplementary Table S2, Supplementary 
Figure S2). The results were unchanged when we assumed a lin-
ear relationship between specimen volume and blood culture 
sensitivity (Supplementary Table S6).
The mean sensitivity of blood culture was predicted to vary 
from 0.51 (95% CI, 0.44–0.57) for a 2-mL specimen to 0.65 
(95% CI, 0.58–0.70) for a 10-mL specimen (Table 2). Sensitivity 
increased by 3% (95% CI, 1%–6%) for each additional milliliter 
of blood cultured (between 1 and 10 mL) according to the linear 
model (Supplementary Table S6).
Age
Differences between studies could be significantly (P  =  .03) 
attributed to the differences in age groups recruited. The diag-
nostic sensitivity was comparable in studies of children (0.59; 
95% CI, 0.50–0.68) and in studies that included both older 
children and adults (0.53; 95% CI, 0.40–0.67), but studies that 
contained only adults had higher sensitivity (0.74; 95% CI, 
0.66–0.81). Between-study heterogeneity within each age group 
was significant except among the studies that recruited adults 
only (Figure 2). Results of the subgroup analysis restricted to 
studies in the meta-regression were comparable, as were the 
results among patients who were bone marrow culture-positive 
only (Figure 2, Supplementary Figure S1). When we added age 
to the best-fit model of specimen volume and sensitivity, the 
model containing an indicator for age category did not provide 
a better fit (Supplementary Table  S3). There were insufficient 
data to test for age-related effect modification between speci-
men volume and sensitivity.
Publication Date
There was a subtle trend toward higher sensitivity among stud-
ies published after 1990 compared with studies published in 
1980–1989 and before 1980 (Supplementary Figure S4), which 
was only significant among the group of studies included in the 
meta-regression analysis using data among all culture-positive 
patients (but not among bone marrow culture-positive patients 
specifically). There was no evidence that this trend was con-
founded by patient age or use of improved techniques for culture 
(Supplementary Table  S8). Restricting our analysis of sample 
volume and sensitivity to studies published after 1980 did not 
change our choice of best-fit model (Supplementary Table S7, 
Supplementary Figure S5, and Supplementary Figure S6).
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Figure 3. Relationship between sample volume and model estimates of blood 
culture sensitivity. The observed blood culture sensitivity among all culture-positive 
cases is plotted in black (with corresponding 95% confidence intervals), whereas 
the mean model-predicted blood culture sensitivity is plotted in dark pink. The 
lighter pink regions correspond to the model-predicted population response. (A) The 
model assumes no correlation with blood volume; (B) the model assumes sensitivity 
increases with increasing sample volume and is constrained to be zero for a hypo-
thetical 0-mL sample; (C) the model assumes sensitivity could vary with sample vol-
ume and estimates an intercept for a hypothetical 0-mL sample. All models account 
for heterogeneity between studies using random effects (see Supplement S4.1).
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Antimicrobial Use and Duration of Illness
Cultures of specimens taken from patients who had been 
exposed to antimicrobials were 34% (95% CI, 4%–54%) less 
sensitive than those from patients with no prior antimicrobial 
use (Figure  4). Furthermore, cultures performed on speci-
mens collected after the first week of illness were 31% (95% CI, 
Table 2. Estimates of Sensitivity by Blood Sample Volumea 
Volume Mean Prediction Population Response
2 mL 0.51 (0.44–0.57) 0.51 (0.30–0.78)
5 mL 0.56 (0.51–0.61) 0.56 (0.38–0.80)
7 mL 0.60 (0.54–0.65) 0.60 (0.42–0.82)
10 mL 0.65 (0.58–0.70) 0.65 (0.46–0.84)
aThe posterior mean prediction and population response of sensitivity, as well as the corresponding 95% credible intervals, from the log-linear meta-regression model are presented for 2, 
5, 7, and 10 mL of blood. The mean prediction is the sensitivity from all studies given a specific volume of blood, whereas the population response is the estimated sensitivity that can be 
expected from a new study that measures sensitivity with samples of a given volume.
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Figure 4. The relative probability of a positive blood culture according to patient history. (A) Relative probability of a positive blood culture for enteric fever patients who 
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19%–41%) less sensitive than cultures of specimens collected 
during the first week (Figure 4). We found no modifying effect 
of antimicrobial use (P = .14) or duration of symptoms (P = .24) 
on the relationship between specimen volume and sensitiv-
ity. Subgroup analyses showed that the impact of symptom 
duration on sensitivity was independent of antimicrobial use 
(P = .88) (Figure 4, Supplementary Table S4).
Risk of Bias Assessment
The greatest risk of bias involved concerns over the applicability 
of patient selection (Figure 5, Supplementary Table S5). Twenty-
five studies (62.5%) were performed in inpatient (hospitalized) 
populations and/or in high-income countries. There was also a 
high risk of bias regarding the reference test (bone marrow cul-
ture) in 14 studies (35%) that cultured less than 1 mL of bone 
marrow (Supplementary Table  S1), potentially missing cases 
with lower bacteremia. For a detailed discussion of the risk of 
bias assessment, see Supplement S5.
DISCUSSION
Our systematic review and meta-analysis synthesized the find-
ings of 40 studies and examined factors affecting blood cul-
ture diagnostic sensitivity. We identified a significant, although 
modest, relationship between specimen volume and blood cul-
ture sensitivity, resonating with observations that have been 
made for other infections [27–29], and confirming a relation-
ship that has been postulated but never quantified [6, 11–14]. 
We estimated that sensitivity of blood culture as a typhoid diag-
nostic method increases from 51% for 2 mL of blood to 65% for 
10 mL, or by 3% for each additional milliliter. Patient age, pub-
lication date, antimicrobial use, and duration of symptoms were 
also associated with changes in blood culture sensitivity, but we 
found no evidence that these factors confounded or modified 
the relationship between specimen volume and sensitivity.
Our estimate of the overall sensitivity of blood culture (irre-
spective of sample volume) is consistent with another recent 
analysis [14], although the authors of that analysis only iden-
tified 10 papers and did not examine the relationship between 
sensitivity and blood sample volume, antibiotic use, symptom 
duration, or publication date. Three studies (Supplementary 
Material; Hoffman 1986, Gasem 1995, Wain 2008) previously 
examined the relationship between sample volume and blood 
culture sensitivity directly, but one of these studies did not 
find conclusive evidence to support the hypothesized rela-
tionship (Supplementary Material, Gasem 1995) and another 
(Supplementary Material, Hoffman 1986) was borderline sig-
nificant (P = .046 by Pearson’s χ2 test). We believe these studies 
were underpowered to detect such an effect. In these 2 studies, 
between 60 and 86 people were recruited, and the difference in 
volume between the 2 blood samples collected from each patient 
was 5–7 mL; according to our analysis, over 400 bone-marrow 
typhoid-positive patients would need to be recruited to detect a 
significant difference in sensitivity. In all studies that collected 
2 blood samples from the same patient, there was no patient 
for whom a larger sample of blood failed to confirm diagnosis 
after isolation of bacteria from the smaller sample; this would 
be highly unlikely if sensitivity were independent of blood vol-
ume (P = 3.12 × 10−36 assuming 56% sensitivity, as predicted by 
the meta-analysis) (Figure 2).
To our knowledge, only 1 study has quantified the relationship 
between blood sample volume and culture sensitivity for other 
pathogens; it found that each additional milliliter yielded a 3% 
increase in sensitivity—consistent with our findings—but the rela-
tionship could not be established for any one specific pathogen [28]. 
1.00
0.75
0.50
0.25
0.00
Patient Selection
Risk of Bias
Patient Selection
Applicability Concerns
Index Test
Risk of Bias
Reference Test
Risk of Bias
Reference Test
Applicability Concerns
Flow & TimingIndex Test
Applicability Concerns
Pr
op
or
tio
n 
of
 S
tu
di
es
Low Unclear High
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However, such an effect has been suggested for Neisseria men-
ingitidis and Streptococcus pneumoniae [30–32]. Only 1 study 
(which was excluded from this analysis because bone marrow 
culture was not conducted concurrently) has quantified the 
effect of age on blood culture sensitivity to detect typhoid [33]. 
That study found that the density of bacteria is inversely related 
to age; thus, patient age may confound the relationship between 
culture volume and sensitivity if smaller samples from children 
achieve similar sensitivity to larger samples from adults [33, 34]. 
However, we found the opposite relationship: there was compa-
rable sensitivity in studies consisting of children only and of older 
children and adults, but higher sensitivity in studies consisting 
of adults only (Figure 2). Furthermore, there was no evidence of 
confounding by age when it was included as a predictor in the 
meta-regression model (Supplementary Table S3).
Sensitivity was also 31% lower among patients whose sam-
ples were collected more than 1 week after symptom onset and 
34% lower among patients who had been previously exposed 
to antimicrobials, relationships that had not been assessed in 
the previous meta-analysis [14]. Similar effects of antimicrobial 
use on blood culture sensitivity have been observed for N men-
ingitidis [28]. The estimated impact of prior antimicrobial use 
was consistent with the findings from one study in our review 
(Supplementary Material, Gasem 2003) found that sensitivity 
decreased by 60% (95% CI, 39%–80%) after 3  days of anti-
microbial use and by 73% (95% CI, 50%–89%) after 5 days of 
antimicrobial use in patients who were blood and bone mar-
row culture-positive before treatment. Antimicrobial use in that 
study was defined as a full course of treatment in a setting with 
limited antimicrobial resistance and completely observed com-
pliance, whereas other studies defined antimicrobial use differ-
ently or in vague terms, which may explain the greater effect. 
Emerging antimicrobial resistance may diminish the negative 
impact of prior antimicrobial use on blood culture sensitivity.
The relationship between blood specimen volume and diag-
nostic sensitivity is weak, and considerable uncertainty remains 
in blood culture sensitivity even after adjusting for specimen 
volume. Blood cultures may have a low sensitivity for enteric 
fever because of low bacterial density in the blood, which is 
often observed in diseases that lack a specific focus of infection 
[12, 27, 35–37]. In our analysis, only 1 study used an automated 
culture system (Supplementary Material, Gasem 2003); there 
was no secular trend in the use of techniques to improve sensi-
tivity (Supplementary Tables S1 and  S8), although there was a 
weak trend towards higher sensitivity in more modern studies 
(Supplementary Figure S5). Although the use of automated sys-
tems may help to improve culture sensitivity for typhoid, this 
may not be feasible in many resource-constrained settings where 
typhoid is endemic; thus, it is also necessary to understand and 
estimate sensitivity according to the culture methods that are 
typically used in such settings. Future studies assessing the sen-
sitivity of blood cultures should ideally collect 2 or more blood 
samples of randomly selected volumes from patients, a sample 
of bone marrow, and data on age, symptom duration, and anti-
microbial use. Our meta-regression framework could then be 
extended to test the joint effects of patient characteristics on the 
relationship between specimen volume and sensitivity.
The studies featured in this analysis likely represent a typi-
cal typhoid patient population. However, most studies (38 of 
40)  were exclusively conducted among hospitalized patients, 
potentially representing more severe cases, whereas only 
1%–20% of cases were hospitalized in population-based sur-
veillance studies [16, 38–40]. Moreover, no studies reported the 
range of symptoms experienced by patients, and, consequently, 
it remains unclear whether more severely affected patients 
(potentially with higher bacteremia) were overrepresented in 
study samples. Furthermore, the sensitivity of bone marrow 
culture (the gold-standard diagnostic) is itself only ~90%, and 
<1 mL of bone marrow was collected in 14 studies (Figure 5, 
Supplementary Table S5). Although we attempted to correct for 
this by considering patients who were positive according to any 
specimen as true positives in our primary analysis, some cases 
may still have been missed, and thus blood culture sensitivity 
may have been overestimated (Supplementary Figure S8).
The evaluation of next-generation serological diagnostics 
depends on the appropriate selection of a “gold” (reference) 
standard to estimate diagnostic accuracy [9, 41–43]. Recent 
studies of rapid-test diagnostics that used blood cultures as the 
reference standard collected specimens ranging from 1 to 10 mL 
[9, 44–46], obfuscating comparisons between studies. Studies that 
use small blood volumes for culture diagnosis may be selecting 
for subjects with higher bacteremia, potentially overestimating 
the sensitivity of the novel diagnostic. Furthermore, such stud-
ies may underestimate the specificity of the novel diagnostic test 
by misclassifying true cases as “false positive” results, especially 
in high-incidence settings, as shown in a previous modeling 
study [9, 42]. The data underscores the importance of recruit-
ing typhoid-negative patients from healthy populations or those 
with a different confirmed infection. Bayesian latent class mod-
els have recently been described to account for the imperfect 
nature of blood culture when evaluating novel diagnostics 
[44, 47, 48]; our findings can inform prior distributions on the 
sensitivity of blood culture according to sample volume.
Our findings have important implications for estimates of the 
burden of typhoid fever and clinical recommendations for the 
diagnosis of enteric fever. Because the degree of underreport-
ing in surveillance studies depends on the volume of blood col-
lected, meta-regression studies that estimate the global burden of 
typhoid fever should adjust for differences in culture sensitivity 
across surveillance studies and between age groups [16, 17, 40]. 
Finally, wherever ethical and regulatory guidelines permit, 
more than 7 mL of blood should be drawn for the diagnosis of 
enteric fever, a recommendation that has been echoed in other 
hospital-based studies [28].
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CONCLUSIONS
In conclusion, our analysis demonstrates that the sensitivity 
of blood culture for detecting infection with S Typhi and S 
Paratyphi is dependent on sample volume, as well as patient 
age, duration of symptoms, and prior antimicrobial use. Further 
prospective studies are needed to better characterize these rela-
tionships. The evaluation of novel diagnostics and efforts to 
integrate data across incidence studies of typhoid fever should 
take into account the potential influence of these factors.
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